STOCK TITAN
  1. Home
  2. MGTA

Magenta Therapeutics (MGTA) Stock Price, News & Analysis

MGTA

Company Description

Magenta Therapeutics (Nasdaq: MGTA) carries a market capitalization of $42.4M.

This page collects what Stock Titan holds for MGTA, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
0.00%
0.00
Last updated:
-
Performance 1 year
$42.4M
Market Cap
0.0
Shares outstanding

Latest News

View All
-14.29%

Magenta Therapeutics and Dianthus Therapeutics Announce Merger Agreement

acquisition
-4.67%

Magenta Therapeutics Adopts Limited Duration Stockholder Rights Plan

+51.66%

Magenta Therapeutics to Explore Strategic Alternatives

-11.09%

Magenta Therapeutics Voluntarily Pauses the MGTA-117 Phase 1/2 Dose-Escalation Clinical Trial to Investigate Drug Safety

clinical trial
-52.71%

Magenta Therapeutics Provides Update for MGTA-117 Phase 1/2 Dose Escalation Clinical Trial

clinical trial
-7.83%

Magenta Therapeutics Presents Positive MGTA-117 Clinical Data at the American Society of Hematology (ASH) Annual Meeting and Provides Program Updates

clinical trial

Magenta Therapeutics has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 6 with negative movement. Key topics include acquisition, clinical trial, conferences, earnings. View all MGTA news →

SEC Filings

View All

No SEC filings available for MGTA.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

Frequently Asked Questions

What is the market cap of Magenta Therapeutics (MGTA)?

The market cap of Magenta Therapeutics (MGTA) is approximately 42.4M. Learn more about what market capitalization means .